Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

AGE AgeX Therapeutics Inc

11,10

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 02:00:00

Verzögert um 15 Minuten

Form S-4/A - Registration of securities, business combinations: [Amend]

0001493152-24-002363.txt

AgeX Therapeutics (AMEX:AGE)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more AgeX Therapeutics Charts.

AgeX Therapeutics (AMEX:AGE)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more AgeX Therapeutics Charts.

News AgeX Therapeutics Inc

AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results
Freitag 22 März 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 425 - Prospectuses and communications, business combinations
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Donnerstag 7 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Montag 5 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 19 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mittwoch 17 Januar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form S-4/A - Registration of securities, business combinations: [Amend]
Dienstag 16 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 11 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere AgeX Therapeutics Inc News-Artikel

Health Care Select Sector

BNP Paribas (QX)

Deutsche Lufthansa

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen